Balticgruppen Bio AB
Records under this name other than patents Balticgruppen Bio AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Balticgruppen Bio AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,675,596 | 1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,162,994 | 1,2,4-thiazoloidin-3-one derivatives and their use in the treatment of cancer Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,691,954 | New Formulations Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,162,850 | Formulations Formerly held In force · USPTO record | In force | USPTO record |